Biocon has informed that a meeting of the Board of Directors of the Company will be held on July 21, 2016, to approve the un-audited financial results for the quarter ended on June 30, 2016 (Q1). The Company will organize a conference call for analysts and investors on July 22, 2016. The details of the call will be available on the Company’s website closer to the scheduled event.
The above information is a part of company’s filings submitted to BSE.